Hagan Joseph P Insider Trading

Get the latest insider transactions of Hagan Joseph P. Hagan Joseph P is Chief Business Officer in Orexigen Therapeutics, Inc. ($OREX) and Sr. VP, Corporate Development in Orexigen Therapeutics, Inc. ($OREX) and Chief Operating Officer in Regulus Therapeutics Inc. ($RGLS) and President and CEO in Regulus Therapeutics Inc. ($RGLS) and in Zosano Pharma Corp ($ZSAN) and Director in Zosano Pharma Corp ($ZSAN). Discover the current value of Hagan Joseph P shares.

Address: C/O OREXIGEN THERAPEUTICS, INC. 3344 N. TORREY PINES COURT, SUITE 200 LA JOLLA 92037CA

Hagan Joseph P is Insider in these Companies

TickerCompany NameCurrent and Previous PositionsTotal SharesCurrent Value ($)
OREXOrexigen Therapeutics, Inc.Chief Business Officer, Sr. VP, Corporate Development13,02659,659.08
ZSANZosano Pharma Corp7,5009,000.00
RGLSRegulus Therapeutics Inc.President and CEO, Chief Operating Officer226,333316,866.20

Insider Trading Transactions of Hagan Joseph P

DateTickerCompanyOwnerRelationship Transaction Cost ($) Shares Transaction Value ($) Total Shares
Jun 29 2020ZSANZosano Pharma CorpHagan Joseph PBuy0.007,50007,500
Jun 05 2020ZSANZosano Pharma CorpHagan Joseph PDirectorOption Exercise1.0115,00015,15015,000
May 18 2020RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOSell0.634,4262,774226,333
Jan 24 2020RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise1.31900,0001,179,000900,000
Dec 26 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise0.007,58507,585
Dec 26 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise0.6775,85050,51675,850
Nov 15 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOSell0.645,8383,736243,428
Oct 15 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise0.641,000,000640,0001,000,000
Oct 15 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise0.641,000,000640,0001,000,000
Oct 02 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOSell0.688,7435,969249,266
Aug 16 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOSell0.554,3752,409258,009
Aug 16 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOSell0.554,3752,409258,009
Jul 18 2019ZSANZosano Pharma CorpHagan Joseph PDirectorOption Exercise2.341,5003,5101,500
Jul 02 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOSell1.315,7837,584262,384
May 16 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOBuy0.00188,3850307,519
May 16 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOSell1.2239,35247,966268,167
May 16 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise0.9510,0009,50010,000
May 08 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOBuy1.0833,19435,85064,542
May 08 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise1.0833,19435,85033,194
Apr 03 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOSell0.985,8425,73131,348
Feb 06 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOBuy0.9565,00061,75084,148
Feb 06 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise0.9565,00061,75065,000
Feb 06 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOBuy0.9565,00061,75084,148
Feb 06 2019RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise0.9565,00061,75065,000
Jun 01 2018ZSANZosano Pharma CorpHagan Joseph PDirectorOption Exercise4.2425,000106,00025,000
May 21 2018RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise0.71725,000514,750725,000
Mar 02 2018ZSANZosano Pharma CorpHagan Joseph PDirectorOption Exercise0.5330,00015,90030,000
Jan 05 2018RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise1.241,000,0001,240,0001,000,000
Jul 25 2017RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOBuy0.91219,780200,000241,297
May 08 2017RGLSRegulus Therapeutics Inc.Hagan Joseph PPresident and CEOOption Exercise1.70750,0001,275,000750,000
Feb 23 2017RGLSRegulus Therapeutics Inc.Hagan Joseph PChief Operating Offic ...Option Exercise1.20160,000192,000160,000
Feb 01 2017RGLSRegulus Therapeutics Inc.Hagan Joseph PChief Operating Offic ...Option Exercise5.7730,000173,10030,000
Nov 04 2016ZSANZosano Pharma CorpHagan Joseph PDirectorOption Exercise0.5820,00011,50020,000
Oct 07 2016RGLSRegulus Therapeutics Inc.Hagan Joseph PChief Operating Offic ...Option Exercise3.5259,625209,88059,625
Mar 07 2016RGLSRegulus Therapeutics Inc.Hagan Joseph PChief Operating Offic ...Buy7.1910,00071,90010,000
Jan 06 2016RGLSRegulus Therapeutics Inc.Hagan Joseph PChief Operating Offic ...Option Exercise8.57420,0003,599,400420,000
May 27 2015ZSANZosano Pharma CorpHagan Joseph PDirectorOption Exercise9.2928,000260,12028,000
Feb 05 2015OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise5.34202,6501,082,151202,650
Sep 15 2014OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Buy4.695,00023,45013,026
Feb 11 2014OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Buy5.343,98021,2533,980
Feb 11 2014OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise6.30225,0001,417,500225,000
Aug 02 2013OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Buy1.6612,00019,92012,000
Aug 02 2013OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Sell7.8012,00093,6000
Aug 02 2013OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise1.6612,00019,920764,000
Jul 29 2013OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Buy1.6610,00016,60010,000
Jul 29 2013OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Sell7.4010,00074,0000
Jul 29 2013OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise1.6610,00016,600776,000
May 30 2013OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Buy1.6628,00046,48028,000
May 30 2013OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Sell7.0028,000196,0000
May 30 2013OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise1.6628,00046,480786,000
Feb 19 2013OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise5.69310,0001,763,900310,000
Jul 13 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Buy1.6630,00049,80030,000
Jul 13 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Sell6.7020,000134,00010,000
Jul 13 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Sell6.9010,00069,0000
Jul 13 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise1.6630,00049,800814,000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Buy1.6670,000116,20070,000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Sell4.9020,00098,00050,000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Sell5.2520,000105,00030,000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Sell5.5030,000165,0000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Buy1.6626,00043,16026,000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Sell5.9026,000153,4000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Buy1.6612,00019,92012,000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Sell6.3012,00075,6000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise1.6670,000116,200882,000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise1.6626,00043,160856,000
Jun 29 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise1.6612,00019,920844,000
Jan 26 2012OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise2.58350,000903,000350,000
Jul 26 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise1.66952,0001,580,320952,000
Jul 26 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise2.83125,000353,7500
Jul 26 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise2.83175,000495,2500
Jul 26 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise6.7450,000337,0000
Jul 26 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise2.9445,000132,3000
Jul 26 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise2.94107,000314,5800
Jul 26 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise1.70450,000765,0000
Jun 14 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PChief Business Office ...Option Exercise1.69450,000760,500450,000
Mar 04 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise5.8945,000265,0500
Mar 04 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise2.9445,000132,30045,000
Mar 04 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise9.31107,000996,1700
Mar 04 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise2.94107,000314,580107,000
Jan 20 2011OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise9.31107,000996,170107,000
Sep 22 2010OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise5.8945,000265,05045,000
Sep 02 2010OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise2.83125,000353,750125,000
Jan 26 2010OREXOrexigen Therapeutics, In ...Hagan Joseph PSr. VP, Corporate Dev ...Option Exercise6.7450,000337,00050,000